Cite
Supplementary Table S2 from A Novel CDC25B Promoter–Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models
MLA
Osvaldo L. Podhajcer, et al. Supplementary Table S2 from A Novel CDC25B Promoter–Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8fde10c4051346c1ea0745170a990387&authtype=sso&custid=ns315887.
APA
Osvaldo L. Podhajcer, Eduardo G. Cafferata, David T. Curiel, Gabriela Acosta Haab, Leonardo Sganga, Cecilia Rotondaro, Edgardo Salvatierra, Santiago Werbajh, Manuel Gidekel, & Helga L. Weber. (2023). Supplementary Table S2 from A Novel CDC25B Promoter–Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models.
Chicago
Osvaldo L. Podhajcer, Eduardo G. Cafferata, David T. Curiel, Gabriela Acosta Haab, Leonardo Sganga, Cecilia Rotondaro, Edgardo Salvatierra, Santiago Werbajh, Manuel Gidekel, and Helga L. Weber. 2023. “Supplementary Table S2 from A Novel CDC25B Promoter–Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8fde10c4051346c1ea0745170a990387&authtype=sso&custid=ns315887.